Ziritaxestat
- Generic Name
- Ziritaxestat
- Drug Type
- Small Molecule
- Chemical Formula
- C30H33FN8O2S
- CAS Number
- 1628260-79-6
- Unique Ingredient Identifier
- I02418V13W
Overview
Ziritaxestat is under investigation in clinical trial NCT03798366 (A Clinical Study to Test How Effective and Safe GLPG1690 is for Patients With Systemic Sclerosis).
Background
Ziritaxestat is under investigation in clinical trial NCT03798366 (A Clinical Study to Test How Effective and Safe GLPG1690 is for Patients With Systemic Sclerosis).
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath